206 related articles for article (PubMed ID: 15704683)
21. Testosterone levels in benign prostatic hypertrophy and prostate cancer.
Mearini L; Costantini E; Zucchi A; Mearini E; Bini V; Cottini E; Porena M
Urol Int; 2008; 80(2):134-40. PubMed ID: 18362481
[TBL] [Abstract][Full Text] [Related]
22. The effect of antiestrogen, antiandrogen, and the prolactin inhibitor 2 bromo-alpha-ergocriptine on the stromal tissue of human benign prostatic hyperplasia. Correlation of stereological data and plasma hormones.
Bartsch G; Oberholzer M; Rohr HP
Invest Urol; 1981 Jan; 18(4):308-12. PubMed ID: 6161105
[TBL] [Abstract][Full Text] [Related]
23. Effect of transurethral resection of prostate on plasma hormone levels in benign prostatic hyperplasia.
Sasagawa I; Nakada T; Suzuki H; Adachi Y; Adachi M
Br J Urol; 1993 Nov; 72(5 Pt 1):611-4. PubMed ID: 10071547
[TBL] [Abstract][Full Text] [Related]
24. Relationship between lower urinary tract symptoms and serum levels of sex hormones in men with symptomatic benign prostatic hyperplasia.
Favilla V; Cimino S; Castelli T; Madonia M; Barbagallo I; Morgia G
BJU Int; 2010 Dec; 106(11):1700-3. PubMed ID: 20575982
[TBL] [Abstract][Full Text] [Related]
25. Impact of radical prostatectomy and TURP on the hypothalamic-pituitary-gonadal hormone axis.
Madersbacher S; Schatzl G; Bieglmayer C; Reiter WJ; Gassner C; Berger P; Zidek T; Marberger M
Urology; 2002 Nov; 60(5):869-74. PubMed ID: 12429318
[TBL] [Abstract][Full Text] [Related]
26. Radical prostatectomy for incidental (stage T1a-T1b) prostate cancer: analysis of predictors for residual disease and biochemical recurrence.
Capitanio U; Scattoni V; Freschi M; Briganti A; Salonia A; Gallina A; Colombo R; Karakiewicz PI; Rigatti P; Montorsi F
Eur Urol; 2008 Jul; 54(1):118-25. PubMed ID: 18314255
[TBL] [Abstract][Full Text] [Related]
27. [A comparative study on different doses of cernilton for preventing the clinical progression of benign prostatic hyperplasia].
Xu J; Qian WQ; Song JD
Zhonghua Nan Ke Xue; 2008 Jun; 14(6):533-7. PubMed ID: 18649754
[TBL] [Abstract][Full Text] [Related]
28. [Data analysis of the objective observation parameters of benign prostatic hyperplasia patients accepting different treatment regimens].
Zhang YG; Wang JY; Liu M; Wan B; Wei D; Deng SM; Xu J; Wu JY; Chu X; Zeng P
Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(24):1690-2. PubMed ID: 19024540
[TBL] [Abstract][Full Text] [Related]
29. Prostate-specific antigen changes as a result of chlormadinone acetate administration to patients with benign prostatic hyperplasia: a retrospective multi-institutional study.
Fujimoto K; Hirao Y; Masumori N; Arai Y; Yamanaka H; Kato T; Miyazawa K
Int J Urol; 2006 May; 13(5):543-9. PubMed ID: 16771723
[TBL] [Abstract][Full Text] [Related]
30. Reduction of length of hospital stay after transurethral resection of prostate by early catheter removal: a retrospective analysis.
Chalise PR; Agrawal CS; Pandit RK
Nepal Med Coll J; 2007 Jun; 9(2):84-7. PubMed ID: 17899954
[TBL] [Abstract][Full Text] [Related]
31. Management of lower urinary tract symptoms secondary to benign prostatic hyperplasia with open prostatectomy: results of a contemporary series.
Helfand B; Mouli S; Dedhia R; McVary KT
J Urol; 2006 Dec; 176(6 Pt 1):2557-61; discussion 2561. PubMed ID: 17085158
[TBL] [Abstract][Full Text] [Related]
32. Gonadal function and immunosuppressive therapy after renal transplantation.
Tondolo V; Citterio F; Panocchia N; Nanni G; Favi E; Brescia A; Castagneto M
Transplant Proc; 2005 May; 37(4):1915-7. PubMed ID: 15919503
[TBL] [Abstract][Full Text] [Related]
33. Recovery of serum prostate specific antigen value after interruption of antiandrogen therapy with allylestrenol for benign prostatic hyperplasia.
Noguchi K; Suzuki K; Teranishi J; Kondo K; Kishida T; Saito K; Uemura H; Kubota Y
Hinyokika Kiyo; 2006 Jul; 52(7):527-30. PubMed ID: 16910584
[TBL] [Abstract][Full Text] [Related]
34. Plasma steroid and protein hormone concentrations in patients with benign prostatic hypertrophy and in normal men.
Ortega E; Ruiz E; Mendoza MC; Martin-Andres A; Osorio C
Experientia; 1979 Jun; 35(6):844-5. PubMed ID: 89045
[TBL] [Abstract][Full Text] [Related]
35. Hormone blood levels and their inter-relationships in normal men and men with benign prostatic hyperplasia (BPH).
Bartsch W; Becker H; Pinkenburg FA; Krieg M
Acta Endocrinol (Copenh); 1979 Apr; 90(4):727-36. PubMed ID: 86267
[TBL] [Abstract][Full Text] [Related]
36. [Treatment of benign prostatic hyperplasia with the preparation Gentos].
Pecherskiĭ AV; Aleksandrov VP; Mazurov VI; Kniaz'kin IV; Zeziulin PN; Nikolaeva EV
Urologiia; 2000; (5):16-7. PubMed ID: 11392216
[No Abstract] [Full Text] [Related]
37. The effect of sirolimus on sex hormone levels of male renal transplant recipients.
Lee S; Coco M; Greenstein SM; Schechner RS; Tellis VA; Glicklich DG
Clin Transplant; 2005 Apr; 19(2):162-7. PubMed ID: 15740550
[TBL] [Abstract][Full Text] [Related]
38. The effect of sexual hormone abnormalities on proximal femur bone mineral density in hemodialysis patients and the possible role of RANKL.
Doumouchtsis KK; Kostakis AI; Doumouchtsis SK; Grapsa EI; Passalidou IA; Tziamalis MP; Poulakou MV; Vlachos IS; Perrea DN
Hemodial Int; 2008 Jan; 12(1):100-7. PubMed ID: 18271850
[TBL] [Abstract][Full Text] [Related]
39. [Cryosurgical ablation for aged patients with severe benign prostate hyperplasia: a report of 21 cases].
Wang AX; Wang D; Tong W
Zhonghua Nan Ke Xue; 2007 May; 13(5):421-3. PubMed ID: 17569258
[TBL] [Abstract][Full Text] [Related]
40. Laser prostatectomy versus transurethral resection of prostate in the treatment of benign prostatic hyperplasia.
Razzaghi MR; Habibi G; Djavid GE; Gholamrezaee H
Saudi Med J; 2007 Jan; 28(1):68-72. PubMed ID: 17206293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
